MedPath
NMPA Approval

Topotecan Hydrochloride for Injection

国药准字HJ20181105

January 12, 2023

H20181105

Drug Information

注射用盐酸托泊替康

和美新

注射剂

1mg

化学药品

January 12, 2023

January 11, 2028

Company Information

Applicant Company

Suurstoffi 14 CH-6343 Rotkreuz Switzerland

Manufacturing Company

glaxosmithkline manufacturing s.p.a.

Strada Provinciale Asolana 90, 43056 San Polo di Torrile, Parma, Italy

© Copyright 2025. All Rights Reserved by MedPath
注射用盐酸托泊替康 - NMPA 批准文号 | MedPath